Nuwellis reports preliminary Q3 revenue ~$2.4M, gross margin 70%, cash $1.9M

Nuwellis, Inc.

2024-Q3 EPS reported -$14.99 revenue$6,418,000

Revenue of approximately $2.4 million; pediatric category grew 28% YoY.
Gross margin improved to 70% from 57.3% YoY; operating costs fell ~30%.
Cash used in ops ~$2.5M; cash and equivalents ~$1.9M at quarter end.
SeaStar settlement: $900K aggregate due by Dec 31, 2024; ~$500K received.
Full Q3 results and earnings call scheduled for November 11, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.